BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

Counterweight Ventures, LLC's Holding History (CIK: 0002012467)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 95,384 Value ($000) $744 Avg Close $7.23 Range $6.00 - $8.17
Q3 2025
Shares 93,384 Value ($000) $709 Avg Close $8.33 Range $7.42 - $9.23
Q2 2025
Shares 93,384 Value ($000) $837 Avg Close $9.31 Range $6.02 - $11.31
Q1 2025
Shares 93,384 Value ($000) $700 Avg Close $8.07 Range $6.96 - $9.50
Q4 2024
Shares 93,384 Value ($000) $702 Avg Close $7.59 Range $6.85 - $8.44
Q3 2024
Shares 93,384 Value ($000) $710 Avg Close $7.60 Range $6.17 - $8.88
Q2 2024
Shares 13,500 Value ($000) $83 Avg Close $5.52 Range $4.03 - $6.99
Q1 2024
Shares 13,500 Value ($000) $69 Avg Close $5.62 Range $4.82 - $7.75
Q4 2023
Shares 13,500 Value ($000) $81 Avg Close $5.79 Range $4.83 - $7.06